Efficacy and safety of two new methods of rapid intravenous detoxification in heroin addicts previously treated without success

British Journal of Psychiatry

Volumn 171, Issue OCT., 1997, Pages 340-345

  Seoane, Albert ^a   Carrasco, Genís ^b   Cabré, Lluís ^b   Puiggrós, Ana ^a   Hernández, Eustaqui ^a   Álvarez, Miguel ^a   Costa, Josep ^b   Molina, Ricard ^b   Sobrepere, Gaudi ^b  

^a PARIS Professionals Associats per la Rehabilitació i la Salut Association   (Spain)

^b Scias Hospital Barcelona   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BENZODIAZEPINE DERIVATIVE; CLONIDINE; DIAMORPHINE; METOCLOPRAMIDE; MIDAZOLAM; NALOXONE; NALTREXONE; OXYGEN; PROPOFOL;

ADULT; ARTICLE; ASPIRATION PNEUMONIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DETOXIFICATION; DRUG EFFICACY; DRUG SAFETY; ENDOTRACHEAL INTUBATION; FEMALE; HEROIN DEPENDENCE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; WITHDRAWAL SYNDROME;

EID: 0030884967     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.171.4.340     Document Type: Article

References (22)

1. American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders (3rd edn, revised). Washington, DC: APA.
2. Altman, D. G. (ed.) (1991) Sample size, hypothesis and power. In Practical Approaches to Medical Research, pp. 396-400. London: Chapman Hall.
3. Brewer, C. (1995) Attitudes to abortion, methadone maintenance and humane opiate withdrawal among health professionals: A depressing analogy. Addiction Research, 3, 1-5.
4. _ (1996) On the specific effectiveness and under-valuing of pharmacological treatments for addiction: a comparison of methadone, naltrexone and disulfiram with psychosocial interventions. Addiction Research, 3, 297-313.
5. Carrasco, G., Molina, R., Costa, J., et al (1993) Propofol versus midazolam in sedation of critically ill patients: cost-benefit analysis. Chest, 103, 557-567.
6. Charney, D. S., Heninger, G. R. & Kleber, H. D. (1986) The combined use of clonidine and naltrexone as a safe, rapid and effective treatment of abrupt withdrawal from methadone. American Journal of Psychiatry, 143, 831-837.
7. Fishbain, D. A., Rosomoff, H. L., Cutler, R., et al (1993) Opiate detoxification protocols. A clinical manual. Annals of Clinical Psychiatry, 5, 53-65.
8. Froehlich, F., Gonvers, J. J. & Fried, M. (1994) Conscious sedation, clinically relevant complications and monitoring of endoscopy: results of a nationwide survey in Switzerland. Endoscopy, 26, 231-234.
9. Gossop, M., Griffiths, P., Bradley, B., et al (1989) Opiate withdrawal symptoms in response to 10 day methadone withdrawal programmes. British Journal of Psychiatry, 154, 360-363.
10. Kosten, T. R. & Kleber, H. D. (1984) Strategies to improve compliance with narcotic agonist. American Journal of Drug and Alcohol Abuse, 10, 249-266.
11. Legarda, J. J. & Gossop, M. (1994) A 24-hour inpatient detoxification treatment for heroin addicts: a preliminary investigation. Drug and Alcohol Dependence, 35, 91-93.
12. Loimer, N., Schmid, R., Presslich, O., et al (1989) Continuous natoxone administration suppresses opiate withdrawal symptoms in human opiate addicts during detoxification treatment. Journal of Psychiatric Research, 23, 81-86.
13. _, _, Lenz, K., et al (1990) Acute blocking of naloxone precipitated opiate withdrawal symptoms by methohexitone. British Journal of Psychiatry, 157, 748-752.
14. _, Lenz, K., Schmid, R., et al (1991) Technique for greatly shortening the transition from methadone to naltrexone maintenance of patients addicted to opiates. American Journal of Psychiatry, 148, 933-935.
15. O'Connor, P. G., Waugh, M. E., Carroll, K. M., et al (1995) Primary-care based ambulatory opioid detoxification. Journal of General Internal Medicine, 10, 255-260.
16. Partridge, B. L. & Ward, C. F. (1986) Pulmonary edema following low-dose naloxone administration. Anesthesiology, 65, 709-710.
17. Plan Nacional sobre Drogas (1994) Prevalencia de la drogadicción. In Memoria 1993 (eds Ministerio de Justicia e Interior), pp. 10-12. Madrid: Ministerio de Justicia e Interior.
18. Riordan, C. H. & Kleber, H. (1980) Rapid opiate detoxification with clonidine and naltrexone. Lancet, i, 1079-1080.
19. San, L., Puig, M., Bulbena, A., el al (1995) High risk of ultrashort noninvasive opiate detoxification. American Journal of Psychiatry, 152, 6.
20. Senft, R. (1991) Experience with clonidine naltrexone for rapid opiate detoxification. Journal of Substance Abuse Treatment, 8, 257-259.
21. Stine, S. M. & Kosten, T. R. (1992) Use of drug combinations in treatment of opioid withdrawal. Journal of Clinical Psychopharmacology, 12, 203-209.
22. Vining, E., Kosten, T. R. & Kleber, H. D. (1988) Clinical utility of rapid clonidine-naltrexone detoxification for opioid abusers. British Journal of Addiction, 83, 567-575.